Screener
Medtronic MDT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Medtronic’s 10-Q, filed September 3, 2026.
- Filed
- Sep 3, 2026, 4:18 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001628280-26-060473
| (in millions, except per share data) | Three months ended / July 31, 2026 | Three months ended / July 25, 2025 |
|---|---|---|
| Income tax provision | 289 | 255 |
| Net income | 1,479 | 1,047 |
| Net income attributable to noncontrolling interests | (9) | (7) |
| Net income attributable to Medtronic | $1,470 | $1,040 |
| Basic earnings per share | $1.15 | $0.81 |
| Diluted earnings per share | $1.14 | $0.81 |
| Basic weighted average shares outstanding | 1,279.8 | 1,281.6 |
| Diluted weighted average shares outstanding | 1,285.1 | 1,287.1 |
Item 1. Financial Statements
FAQ
- What is Medtronic's EPS (diluted)?
- Medtronic (MDT) reported EPS (diluted) of $1.14 in Q2 2026.
- How has Medtronic's EPS (diluted) changed year-over-year?
- Medtronic's EPS (diluted) increased by 40.7% year-over-year, from $0.81 to $1.14.
- What is the long-term trend for Medtronic's EPS (diluted)?
- Over 4 years (2022 to 2026), Medtronic's EPS (diluted) has grown at a 0.1% compound annual growth rate (CAGR), from $3.73 to $3.74.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Medtronic's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude